ǰÑÔ
Ñ×Ö¢ÐÔ³¦²¡(inflammatory bowel disease,IBD) ÊÇÒ»ÖÖ²¡ÒòºÍ·¢²¡»úÖÆÈÔ²»Ê®·ÖÇåÎúµÄ賦µÀÂýÐÔ·ÇÌØÒìÐÔÑ×Ö¢ÐÔ¼²²¡£¬°üÀ¨À£ÑñÐԽ᳦Ñ×(ulcerative colitis,UC)ºÍ¿ËÂÞ¶÷²¡(Crohn disease,CD)¡£IBDÁÙ´²ÌåÏÖΪ¼±ÐÔ±¬·¢Ó뻺½âÏà½»Ìæ£¬²¡³ÌǨÑÓÖØ¸´¡£¶àÒòËØ×ÛºÏÆÊÎöÅú×¢£ºËÞÖ÷»ùÒòµ¼ÖµÄÒÅ´«Ò׸С¢²¡ÔÌåѬȾÔì³ÉµÄ³¦µÀ΢Éú̬ʧµ÷¡¢ÇéÐÎÒòËØ£¨ÈçÒûʳ¡¢¼¾½Ú¡¢Ó¦¼¤µÈ£©µÄ×ÛÏàÖúÓ㬵¼Ö»úÌåÃâÒßÓ¦´ðµÄÒì³££¬ÊÇIBD±¬·¢µÄÖ÷ÒªÔµ¹ÊÔÓÉ¡£´Ë¿´·¨³ÉΪIBD¶¯ÎïÄ£×Ó½¨ÉèµÄÀíÂÛÒÀ¾Ý¡£UCºÍCDÔÚ²¡ÀíÌØµãºÍ²¡±ä²¿Î»µÈ·½Ãæ¼ÈÓй²ÐÔ£¬ÓÖ¸÷¾ßÌØµã£¬µ«ÔÚ·¢²¡ÓÕÒò¡¢ÁÙ´²ÌåÏÖºÍÖÎÁÆÔÔòÉÏÓÖ»ùÄÚÇéͬ¡£ÔÚÄ£×ÓÖÆ±¸ÉÏÁËÒÔUC¶à¼û£¬µ«ÓÐʱ²»×öÑÏ¿áÇø·Ö¡£½üÄêÀ´£¬ÎÒ¹úIBD·¢²¡ÂÊÓÐÖð½¥ÉÏÉýÇ÷ÊÆ¡£ºã¾Ã¡¢Öظ´µÄÂýÐÔ³¦Ñ×£¬ÓпÉÄܵ¼Ö½᳦°©µÄ±¬·¢¡£Òò´Ë£¬½¨ÉèIBD¶¯ÎïÄ£×Ó¹ØÓÚÆÊÎöIBDµÄ²¡ÒòºÍ·¢²¡»úÖÆ´Ó¶øµÖ´ïÓÐÓ÷ÀÖεÄÄ¿µÄ£¬¾ßÓÐÖ÷ÒªµÄÏÖʵÒâÒå¡£
Æù½ñÒÑÓеÄlBDÄ£×Ó´óÖ·ÖΪ×Ô¾õÄ£×Ó¡¢ÓÕ·¢Ä£×ӺͻùÒòÐÞÊÎÄ£×Ó¡£¹ØÓÚ»ùÒòÐÞÊÎÄ£×ÓµÄÔÀí¡¢ÌØµãÒÔ¼°×Ô¾õÄ£×ÓµÄÏà¹ØÖªÊ¶£¬ÔÚ±¾Êé×ÜÂÛµÄÏìÓ¦Õ½ÚÓÐÏêϸÐðÊö¡£ÓÕ·¢Ä£×ÓÊÇIBD¶¯ÎïÄ£×ÓµÄÖ÷ҪȪԴ£¬Ò²ÊDZ¾½ÚÖØµãÏÈÈݵÄÄÚÈÝ¡£
»ùÒòÐÞÊÎIBD¶¯ÎïÄ£×Ó°üÀ¨»ùÒòÇóýºÍת»ùÒòÄ£×Ó¡£ÓÉÓÚ»ùÒòÐÞÊÎÄ£×ÓÊÖÒÕÒªÇó¸ß¡¢Î¹Ñø¼°×ÌÉúÌõ¼þÑϿᣬÏÖÔÚº£ÄÚÓ¦ÓÃÓÚIBDÑо¿Ïà¶Ô½ÏÉÙ£¬¿ÉÊÇ»ùÒòÐÞÊÎÄ£×ÓÊÇÓÐÍûÒÔºóÓÐËùÍ»ÆÆµÄÑо¿ÈÈÃÅ¡£ÏÂÃæÒÔTϸ°ûαÊÜÌå(T cell receptor,TCR-a)»ùÒòÇóýºÍ°×½éËØ7(IL-7)ת»ùÒòÄ£×ÓΪÀý£¬×öÒ»¼òÆÓÏÈÈÝ¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
TCRÊǽ鵼Tϸ°ûÃâÒß·´Ó¦µÄÖ÷ÒªÊÜÌ壬¼ÓÈ뿹ԵÄʶ±ðºÍµÝ³Ê¡£TCR-a»ùÒòÇóý(TCR-α-/-£©Ð¡Ê󱻯ձéÓÃÓÚÑо¿³¦µÀTϸ°ûÓ볦µÀϸ¾ú¿¹ÔÔÚIBD·¢²¡ÖеÄÏ໥×÷Óá£
ð¤Ä¤ÉÏÆ¤±¬·¢µÄIL-7¹ØÓÚÉÏÆ¤ºÍð¤Ä¤ÄÚÁܰÍϸ°ûµÄÔöÖ³¼°¹¦Ð§µ÷ÀíÖÁ¹ØÖ÷Òª¡£IL-7ת»ùÒòСÊóÌ«¹ý±í´ïIL-7£¬Ê¹ð¤Ä¤ÁܰÍϸ°û´ó×Ú¼¤»î´Ó¶ø¶Ô½á³¦Ñׯðά³Ö×÷Óá£
¡¾ÔìÄ£ÒªÁì¡¿£º
ͨ¹ý»ùÒò´ò°ÐÒªÁì¸Ä±äСÊóÅßÌ¥¸Éϸ°ûTCR-α»ùÒòµÄµÚÒ»¸öÍâÏÔ×Ó£¬±¬·¢TCR-α-/-СÊó¡£TCR-α-/-СÊóÔÚ16ÖÜʱ·ºÆð½á³¦Ñס£
ʹÓÃת»ùÒòÊÖÒÕ½«Ð¡ÊóIL-7cDNAÓëSRαÆô¶¯×ÓÅþÁ¬£¬½«SRα/lL-7DNAƬ¶ÏÏÔ΢עÈëC57BL/6JСÊóµÄÊܾ«ÂÑÖУ¬Í¨¹ý¶ÔÓ×ÊóµÄDNAÓ¡¼£ÆÊÎö£¬É¸Ñ¡³öIL-7ת»ùÒòÑôÐÔµÄСÊ󣬸ÃСÊóÔÚ1~3ÖÜʱ¿É·ºÆð½á³¦Ñס£
¡¾Ä£×ÓÌØµã¡¿£º
TCR-α-/-СÊóµÄ½á³¦Ñ×ÌåÏÖΪһÁ¬ÐÔ¸¹Ðº£¬²¡Àí¿É¼ûÈ«½á³¦·Êºñ¡¢³¦ð¤Ä¤Ñ×ÐÔϸ°û½þÈó¡¢ÉÏÆ¤ÔöÉú¡¢ÒþÎÑŧÖ×»òȱʧ¡¢±×´Ï¸°û¼õ ÉÙ£¬µ«Ð¡³¦Î´ÊÜÓ°Ïì¡£
IL-7ת»ùÒòСÊó8~12ÖÜÁäʱ·ºÆðÍѸغͱãѪ£¬³¦¹ÌÓвãÃÖÂþÐÔÖÐÐÔÁ£Ï¸°û¡¢TÁܰÍϸ°ûºÍµ¥ºËϸ°û½þÈ󣬱״ϸ°ûïÔÌ¡¢ÒþÎÑŧÖ׵ȡ£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
TCR-α-/-СÊó½á³¦Ñ×µÄ×éÖ¯²¡ÀíѧºÍÃâÒßÑ§ÌØÕ÷¾ùÓëUCÀàËÆ£¬Ö÷Ҫͨ¹ýTh2»úÖÆ¶Ô³¦µÀ¿¹Ô£¨°üÀ¨Õý³£Ï¸¾úºÍʳÎ±¬·¢ÃâÒß·´Ó¦¡£¸ÃÄ£×Ó¿ÉΪÑо¿UCµÄÃâÒßѧ»úÖÆÌṩ×ÊÖú¡£
²Î¿¼ÎÄÏ×£º
1.ÍõȺӢ£¬³Â´åÁú£¬Íõ¼ÌµÂ£¬µÈ£®ÆÏ¾ÛÌÇÁòËáÄÆÖÂÀ£ÑñÐԽ᳦Ñ×СÊóÄ£×ӵĽ¨É裮µÚÒ»¾üÒ½´óѧѧ±¨£¬2002,22 (7):608-610
2.ÁÖÆ½£¬Ð¤À¼£¬ÖÜæÃ£¬µÈDNCBËùÖÂСÊó½á³¦Ñ×ÓëLMIFµÄ¹ØÏµ£®Öйú²¡ÀíÐÄÀíÔÓÖ¾£¬2004,20(10): 1778-1782
3.Glick ME, Falchuk ZM. Dinilrochlorobenzene-induced colitis in the guinea-pig:studies of colonic lamina propria lymphocytes. Gut, 1981,22(2): 120-125
4.Madara JL,Podolsky DK,King NW,el al. Characterization of spontaneous colitis in Cotton-Top Tamarin (Saguinus Oedipus) and its response to sulfasalazine. Gastroenterology,1985, 88 (1 Pt 1): 13-19
5.Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell, 1993, 75 (2): 274-282
6.Rabin BS, Rogers SJ. A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology, 1978,75 (1) 29-33
7.Sundberg JP, Elson CO, Bedigian H,et al. Spontaneous,heritable colitis in a new suhstrait of C3H/HeJ mice. Gastroenterology,1994,107 (6): 1726-1735
8.Thippeswamy BS,Mahendran S,Biradar MI,et al. Protective effect of embelin against acetic acid induced ulcerativecolitis in rats. Eur J Pharmacol, 2011, 654 (1): 100-105
9.Watanabe M, Ueno Y, Yajima T, et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med, 1998, 187 (3):389-402
10.ÕÅÊç·¼£¬ÎâСƽ£¬Â¬·Å¸ù. ÂýÐÔÓ¦¼¤¶ÔСÊóÀ£ÑñÐԽ᳦Ñ×µÄÓ°Ï죮¹ú¼ÊÏû»¯²¡ÔÓÖ¾£¬2008,28 (6):520-523
11.Hodgson HJF, Potter BJ,Skinner J, et al. immune-complex mediated colitis in rabbits-An experimental model. Gut, 1978, 19(3):225-232